This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Drug Interaction Potentiation
and you are
between 20 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine if Losartan potassium is affected by PA21.

Provided treatments

  • Drug: PA21 and Losartan with Food
  • Drug: No PA21; Losartan with food
  • Drug: PA21 with food and Losartan 2 hours later

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01324752. The sponsor of the trial is Vifor Inc. and it is looking for 36 volunteers for the current phase.
Official trial title:
A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Losartan Potassium in Healthy Male and Female Adults